Proofpoint Inc (PFPT)
We assign a fundamental rating of 3 out of 10 to PFPT. PFPT was compared to 279 industry peers in the Software industry. The financial health of PFPT is average, but there are quite some concerns on its profitability. PFPT is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
PFPT had positive earnings in the past year.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.87% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | -11.6% | ||
| PM (TTM) | -15.16% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
PFPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.57 indicates that PFPT is not a great score, but indicates only limited risk for bankruptcy at the moment.
PFPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.57 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
PFPT has a Current Ratio of 1.37. This is a normal value and indicates that PFPT is financially healthy and should not expect problems in meeting its short term obligations.
PFPT has a Quick Ratio of 1.37. This is a normal value and indicates that PFPT is financially healthy and should not expect problems in meeting its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
PFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.84%, which is quite good.
The Earnings Per Share has been growing by 55.54% on average over the past years. This is a very strong growth
The Revenue has grown by 16.27% in the past year. This is quite good.
The Revenue has been growing by 31.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)16.84%
EPS 3Y33.84%
EPS 5Y55.54%
EPS Q2Q%23.53%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y26.42%
Revenue growth 5Y31.66%
Sales Q2Q%19.43%
3.2 Future
PFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.44% yearly.
Based on estimates for the next years, PFPT will show a quite strong growth in Revenue. The Revenue will grow by 15.32% on average per year.
EPS Next Y16.1%
EPS Next 2Y17.24%
EPS Next 3Y15.17%
EPS Next 5Y11.44%
Revenue Next Year18.38%
Revenue Next 2Y18.01%
Revenue Next 3Y16.1%
Revenue Next 5Y15.32%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PFPT is valuated quite expensively with a Price/Earnings ratio of 79.23.
The average S&P500 Price/Earnings ratio is at 28.96. PFPT is valued rather expensively when compared to this.
PFPT is valuated quite expensively with a Price/Forward Earnings ratio of 64.31.
The average S&P500 Price/Forward Earnings ratio is at 23.82. PFPT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 79.23 | ||
| Fwd PE | 64.31 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 108.23 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as PFPT's earnings are expected to grow with 15.17% in the coming years.
PEG (NY)4.92
PEG (5Y)1.43
EPS Next 2Y17.24%
EPS Next 3Y15.17%
5. Dividend
5.1 Amount
No dividends for PFPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Proofpoint Inc
NASDAQ:PFPT (8/30/2021, 8:56:08 PM)
After market: 175.91 +0.01 (+0.01%)175.9
-0.04 (-0.02%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.16B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 79.23 | ||
| Fwd PE | 64.31 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.92
PEG (5Y)1.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.87% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | -11.6% | ||
| PM (TTM) | -15.16% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)16.84%
EPS 3Y33.84%
EPS 5Y
EPS Q2Q%
EPS Next Y16.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.27%
Revenue growth 3Y26.42%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y